Immunovant, Inc. (IMVT)
24.76
+0.92
(+3.86%)
USD |
NASDAQ |
Mar 25, 16:00
24.73
-0.03
(-0.12%)
After-Hours: 06:13
Immunovant Total Assets (Quarterly) : 1.052B for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 43.67B |
| Plus Therapeutics, Inc. | 16.32M |
| Viridian Therapeutics, Inc. | 899.42M |
| Nutriband, Inc. | 8.419M |
| Definium Therapeutics, Inc. | 440.10M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.26M |
| Shareholders Equity (Quarterly) | 986.14M |
| Current Ratio | 15.74 |
| Net Debt Paydown Yield | 0.00% |